【中医药英文刊巡礼】-《中医科学杂志（英文）》⑬

期刊介绍

Journal of Traditional ChineseMedical Sciences

《中医科学杂志（英文）》

《中医科学杂志(英文)》是中医药范畴的同业评审杂志，创刊于2014年7月(季刊),由教育部主管，北京中医药大学和清华大学出书社结合主办，国际出书集体Elsevier负责在线出书和开放获取。本杂志致力于搭建最具权势性的英文..，向国际输出最前沿的中医药研究功效。杂志首要收录原创研究类文章，内容笼盖中医、中药、针灸范畴，包罗各类根蒂和临床研究，以及综述、政策新闻和病例申报。杂志今朝已被中国知网(CNKI)，维普(VIP)，万方(Wanfang)，DOAJ，Embase，GoogleScholar，Scopus等国表里数据库收录。近年来，获得“中国最美期刊”“中国高校精良科技期刊”等声誉称号。

Journal of Traditional Chinese Medical Sciences(JTCMS) is an international, peer-reviewed publication with advanced scientific research in traditional Chinese medicine (TCM). Founded in July 2014 and published quarterly, the journal is sponsored by Beijing University of Chinese Medicine and Tsinghua University Press, and supervised by the Ministry of Education of China. The Elsevier B.V. is responsible for online publication and open access. JTCMS tries to serve as an authoritative platform to present state-of-the-art research results. We welcome submissions of original papers on experimental and clinical studies on TCM, herbs and acupuncture that apply modern scientific research methods. The journal also publishes case reports, reviews, and articles on TCM theory and policy.In recent years, JTCMS has been included in the China National Knowledge Infrastructure (CNKI), Chinese Scientific Journal Database (VIP), Wanfang Data, DOAJ, Embase, Google scholar, and Scopus. In addition, the journal has been titled as"The Beauty of Periodicals in China"and "Excellent Science & Technology Journals in Chinese Universities."

主编介绍

Editors-in-Chief

徐安龙

徐安龙传授，北京中医药大学校长，博士生导师，历久从事分子免疫学和系统生物学研究。2007年被聘为973规划项目首席科学家，2011年被聘为科技部重大研究规划专家构成员，2021年入选岐黄学者，一连9年被Elsevier评为"中国高被引学者”。先后荣获“高校十大科技进展”、国度天然科学奖二等奖(第一完成人)、“中国生命科学十猛进展”、广东省科学手艺奖等多项省部级及国度级科研奖励，2022年荣获第十四届“谈家桢生命科学奖”-谈家桢生命科学成就奖。作为通信作者在Nature，Cell，Cell Res，Nat Commun，PNAS等国际学术刊物上揭橥200余篇高水平论文。

Professor Xu Anlong is president of Beijing University of Chinese Medicine and a doctoral supervisor. He has been engaged in molecular immunology and systems biology research for a long time. He has also participated in many organizations and became the chief scientist of the 973 Program (National key basic research and development program) in 2007, a member of the expert group of the major research plan of the Ministry of Science and Technology in 2011 and a Qihuang Scholar in 2021. He has been rated as a highly cited Chinese researcher by Elsevier for nine consecutive years.In addition, he has won the second prize of "Ten Major Scientific and Technological Progress of Colleges and Universities" and National Natural Science Award (the first completed person), provincial and national scientific research awards such as Top 10 Scientific Advances in Life Sciences of China and Guangdong Provincial Science and Technology Award as well as the 14th C.C.Tan Life Science Achievement Award in 2022. As for paper, he published more than 200 high-level papers in international academic journals such as Nature, Cell, Cell Res, Nat Commun, and PNAS as the corresponding author.

相关信息

主管单元单子：..教育部

主办单元单子：北京中医药大学清华大学出书社有限公司

刊号：CN: 10-1218/R

刊期：季刊

官网网址：https://qikan.bucm.edu.cn/homeNav?lang=zh

投稿网址：https://www.editorialmanager.com/jtcms/default1.aspx

关联德律：010-53911862

电子邮箱：bucmjtcms@vip.163.com

地 址：北京中医药大学良乡校区西院综合楼